The estimated Net Worth of Christy L Shaffer is at least $2.1 Миллион dollars as of 29 September 2020. Christy Shaffer owns over 18,750 units of Clearside Biomedical Inc stock worth over $2,102,864 and over the last 8 years he sold CLSD stock worth over $0. In addition, he makes $0 as Independent Chairman of the Board at Clearside Biomedical Inc.
Sign up
Christy Shaffer CLSD stock SEC Form 4 insiders trading
Christy has made over 4 trades of the Clearside Biomedical Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 18,750 units of CLSD stock worth $300,000 on 29 September 2020.
The largest trade he's ever made was buying 18,750 units of Clearside Biomedical Inc stock on 29 September 2020 worth over $300,000. On average, Christy trades about 1,218 units every 68 days since 2017. As of 29 September 2020 he still owns at least 1,605,240 units of Clearside Biomedical Inc stock.
You can see the complete history of Christy Shaffer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Christy Shaffer biography
Dr. Christy L. Shaffer Ph.D. serves as Independent Chairman of the Board of the Company. Dr. Shaffer has served as a director of our company since 2012 and as the chairman of our board of directors from 2012 to February 2018. Since 2011, Dr. Shaffer has served as a Venture Partner with Hatteras Venture Partners, an investment firm, and as Managing Director of Hatteras Discovery, which invests in early-stage companies in the life sciences industry sector. From 1995 to 2010, Dr. Shaffer served in increasing leadership positions at Inspire Pharmaceuticals, a publicly held biopharmaceutical company, beginning as the company’s first full-time employee and Director of Clinical Operations and eventually being appointed as Chief Executive Officer and a director of the company in 1999, as its President in 2005 and a member of its Development Committee in 2009. Prior to Inspire, she was a clinical research scientist, international project leader and Associate Director of Pulmonary and Critical Care Medicine at Burroughs Wellcome Co. Dr. Shaffer currently serves as a board member of the Chordoma Foundation and has served in leadership roles on several non-profit boards, including as chair of the Morehead Planetarium and Science Center’s advisory board, on the Board of Trustees for the Cystic Fibrosis Foundation, and as chair of the board of CFF Therapeutic, Inc. Dr. Shaffer served on the board of G1 Therapeutics, Inc., a publicly traded biopharmaceutical company, from 2012 to June 2018. Dr. Shaffer is a receptor pharmacologist by training, earning her Ph.D. in Pharmacology from the University of Tennessee’s Health Science Center in Memphis, Tennessee. She completed post-doctoral training at The Chicago Medical School as well as the University of North Carolina at Chapel Hill. Our board of directors believes that Dr. Shaffer’s scientific background and her leadership experience as chief executive officer of a public company in the biopharmaceutical industry provides her with the qualifications and skills to serve as a di
How old is Christy Shaffer?
Christy Shaffer is 62, he's been the Independent Chairman of the Board of Clearside Biomedical Inc since 2012. There are 5 older and 8 younger executives at Clearside Biomedical Inc. The oldest executive at Clearside Biomedical Inc is Nancy Hutson, 70, who is the Independent Director.
What's Christy Shaffer's mailing address?
Christy's mailing address filed with the SEC is C/O CLEARSIDE BIOMEDICAL, INC., 900 NORTH POINT PARKWAY, SUITE 200, ALPHARETTA, GA, 30005.
Insiders trading at Clearside Biomedical Inc
Over the last 8 years, insiders at Clearside Biomedical Inc have traded over $11,999,807 worth of Clearside Biomedical Inc stock and bought 4,477,928 units worth $22,264,136 . The most active insiders traders include Bradford T Whitmore, Clay Thorp и Venture Advisors Iv Sbic, L.... On average, Clearside Biomedical Inc executives and independent directors trade stock every 30 days with the average trade being worth of $82,593. The most recent stock trade was executed by Ngai Hang Victor Chong on 24 June 2024, trading 23,500 units of CLSD stock currently worth $24,910.
What does Clearside Biomedical Inc do?
clearside biomedical, inc. is a pharmaceuticals company located in 1220 old alpharetta rd., suite 300, alpharetta, ga, united states.
What does Clearside Biomedical Inc's logo look like?
Complete history of Christy Shaffer stock trades at Clearside Biomedical Inc, G1 Therapeutics Inc и Graybug Vision
Clearside Biomedical Inc executives and stock owners
Clearside Biomedical Inc executives and other stock owners filed with the SEC include:
-
George Lasezkay,
President, Chief Executive Officer, Director -
Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.,
Pres, CEO & Director -
Dr. George M. Lasezkay Pharm.D., Pharma.D., J.D.,
Pres, CEO & Director -
Charles Deignan,
Chief Financial Officer -
Dr. Thomas A. Ciulla M.B.A., M.D.,
Chief Medical Officer & Chief Devel. Officer -
Charles A. Deignan,
Chief Financial Officer -
Jenny Kobin,
IR Contact Officer -
Clay Thorp,
Independent Director -
Nancy Hutson,
Independent Director -
William Humphries,
Independent Director -
Jeffrey Edwards,
Independent Director -
Richard Croarkin,
Independent Director -
Christy Shaffer,
Independent Chairman of the Board -
Susan L. Coultas Ph.D.,
Chief Clinical Officer -
Rick McElheny,
VP of Corp. Devel. -
Leslie B. Zacks,
Gen. Counsel, Chief Compliance Officer & Sec. -
Jenny R. Kobin,
Head of Investor Relations -
Venture Advisors Iii, Llc H...,
-
Venture Advisors Iv Sbic, L...,
-
Venture Advisors Iii, Llc H...,
-
Evgeny Zaytsev,
Director -
Daniel H. White,
President and CEO -
Investments S.A.R.L.Rusnano...,
-
Derek Yoon,
Director -
Gerald D. Cagle,
Director -
Venture Advisors Iv Sbic, L...,
-
Glenn Noronha,
Executive Vice President, R&D -
Thomas Ciulla,
Chief Medical Officer -
Brion S. Raymond,
Chief Commercial Officer -
Anthony S Gibney,
-
Bradford T Whitmore,
10% owner -
Ngai Hang Victor Chong,
Chief Medical Officer -
Benjamin R Yerxa,